“Month 60 Outcomes After Treatment Initiation With Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion”, Am J Ophthalmol, vol. 240, pp. 330-341, 2022.
, “A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial”, Transplant Cell Ther, vol. S2666-6367, no. 22, pp. 01467-1, 2022.
, “An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cT) cells and antibody responses.”, Vaccine, vol. 40, no. 49, pp. 7065-7072, 2022.
, “The Opioid Use Disorder Core Outcomes Set (OUD-COS) for Treatment Research: Findings from a Delphi Consensus Study”, Addiction, vol. 17, no. 9, pp. 2438-2447, 2022.
, “Pain Matters! NINDS Cerebral Palsy Common Data Elements, International Classification of Functioning, And Measures of Pain in Children With Cerebral Palsy, Mini-Symposium”, in 76th Annual American Academy for Cerebral Palsy and Developmental Medicine Meeting, 2022.
, “Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy”, Matern Child Health J, vol. 26, no. 7, pp. 1488-1495, 2022.
, “PfSPZ-CVac Malaria Vaccine Demonstrates Safety Among Malaria-experienced Adults: A Randomized, Controlled Phase 1 Trial”, EClinicalMedicine, vol. 52, p. 101579, 2022.
, “Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults.”, Antimicrob Agents Chemother, vol. 66, no. 12, p. e0093622, 2022.
, “A Phase 1 Dose-Sparing, Randomized Clinical Trial of Seasonal Trivalent Inactivated Influenza Vaccine Combined With MAS-1, A Novel Water-In-Oil Adjuvant/Delivery System”, Vaccine, vol. 40, no. 9, pp. 1271-1281, 2022.
, “A Phase I Randomized, Double-blind, Single Subcutaneous Dose Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of Rezafungin in Healthy Adult Subjects”, Clin Transl Sci, vol. 15, no. 7, pp. 1592-1598, 2022.
, “Population Pharmacokinetics of Moxifloxacin in Children”, Paediatr Drugs, vol. 24, no. 2, pp. 163-173, 2022.
, “Process and Strategies for Patient Engagement and Outreach in the Sickle Cell Disease (SCD) Community to Promote Clinical Trial Participation”, J Natl Med Assoc, vol. 114, no. 2, pp. 211-217, 2022.
, “Qualitative Results from NIDA Grant”, Maternal Child Health, vol. 26, no. 7, 2022.
, “A Randomized Controlled Trial Showing Safety and Efficacy of A Whole Sporozoite Vaccine Against Endemic Malaria”, Sci Transl Med, vol. 14, no. 674, p. eabj3776, 2022.
, “Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies”, J Clin Oncol, vol. 40, no. 4, pp. 356-368, 2022.
, “Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.”, Lancet Infect Dis, vol. 22, no. 8, pp. 1210-1220, 2022.
, “Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults”, Vaccine, vol. 40, no. 47, pp. 6740-6746, 2022.
, “Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.”, Antimicrob Agents Chemother, vol. 66, no. 12, p. e0093522, 2022.
, “Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.”, Contemp Clin Trials Commun, vol. 30, p. 101025, 2022.
, “Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial”, JAMA Pediatr, vol. 176, no. 3, pp. 253-261, 2022.
, “Successful Implementation of Substance Use Screening in Rural Federally-Qualified Health Centers Identified High Rates of Unhealthy Alcohol, Cannabis, and Tobacco Use”, in The College on Problems of Drug Dependence (CPDD), Minneapolis, MN, 2022.
, “Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.”, N Engl J Med, vol. 386, no. 24, pp. 2273-2282, 2022.
, “Use of Population Modeling to Characterize the Pharmacokinetics of Oxcarbazepine And Its Metabolite in Children and Adolescents with Obesity”, in Annual Meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT), Virtual, 2022.
, “Assessment of Screening Tools to Identify Substance Use Disorders Among Adolescents”, JAMA Netw Open, vol. 6, no. 5, p. e2314422, 2023.
, “Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.”, Lancet Diabetes Endocrinol, vol. 11, no. 6, pp. 391-401, 2023.
,